Telogen effluvium revisited

被引:3
|
作者
Rebora, A. [1 ]
机构
[1] Univ Genoa, Genoa, Italy
来源
关键词
Hair; Alopecia; Alopecia etiology; ALOPECIA-AREATA INCOGNITA; HAIR-GROWTH CYCLE; ANDROGENETIC ALOPECIA; HUMAN SCALP; ANAGEN HAIR; CLUB FIBER; SERUM ZINC; EXOGEN; DIAGNOSIS; FOLLICLE;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Telogen effluvium (TE) is heterogeneous disorder. It can be classified into three main categories: the premature teloptosis, the collective teloptosis and the premature entry into telogen. The last category can be divided in three types: the drug induced TE, TE due to dietary deficiencies and the "autoimmune" TE. Despite this heterogeneity, the large majority of TE that arrive at the dermatologist's observation pertain to the autoimmune type, featuring a standard presentation. The typical patient is a woman claiming to have always had a "full head of hair" and reporting her hair to come out suddenly "by the handful". Usually, she is accurate about the date of onset of her shedding. She is in good health, without signs of anorexia nor nutrient deficiencies. She admits to having been in an anxious state for some months, and felt, occasionally or not, a painful or burning sensation at the scalp (trichodynia). Usually, the course of the disorder is chronic but intermittent, with apparent remissions being irregularly intermitted by relapses. The shed hairs do not exhibit telogen roots, but mostly exogen ones. This distinct entity, shares some analogies with alopecia areata, including the triggering role of emotional stress, trichodynia and the frequent association with Hashimoto's thyroiditis. Methods to assess its severity and to monitor treatment are described. In the absence of a documented etiopathogenesis, no treatment can be endorsed, but a course of topical corticosteroids could be tried.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [41] Telogen Effluvium: Is There a Need for a New Classification? A Reply
    Rebora, Alfredo
    SKIN APPENDAGE DISORDERS, 2018, 4 (01) : 29 - 30
  • [42] Chronic telogen effluvium: a systematic review of interventions
    Daunton, A.
    Harries, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 52 - 52
  • [43] Telogen effluvium caused by magnesium valproate and lamotrigine
    Patrizi, A
    Savoia, F
    Negosanti, F
    Posar, A
    Santucci, M
    Neri, I
    ACTA DERMATO-VENEREOLOGICA, 2005, 85 (01) : 77 - 78
  • [44] Thyroid peroxidase antibodies in patients with telogen effluvium
    Baldari, M.
    Guarrera, M.
    Rebora, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (08) : 980 - 982
  • [45] Telogen Effluvium, Diagnosis and Management: A Narrative Review
    Hussein, Ramadan S.
    Bin Dayel, Salman
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2023, 13 (01) : 26 - 30
  • [46] Telogen effluvium: a sequela of COVID-19
    Mieczkowska, Karolina
    Deutsch, Alana
    Borok, Jenna
    Guzman, Anthony K.
    Fruchter, Renee
    Patel, Parth
    Wind, Olivia
    McLellan, Beth N.
    Mann, Ranon E.
    Halverstam, Caroline P.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (01) : 122 - 124
  • [47] Telogen effluvium as first clinical presentation of dengue
    Veraldi, Stefano
    Vaira, Fabrizio
    Raia, Daniele D.
    Barbareschi, Mauro
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (02): : 184 - 185
  • [48] COVID-19 induced telogen effluvium
    Aksoy, Hasan
    Yildirim, Umut Mert
    Ergen, Pinar
    Gurel, Mehmet Salih
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [49] Acute telogen effluvium triad after resolution
    Contin, Leticia Arsie
    Rocha, Vanessa Barreto
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2021, 96 (05) : 605 - 608
  • [50] Telogen effluvium associated with COVID-19 infection
    Olds, Hailey
    Liu, Jesse
    Luk, Kevin
    Lim, Henry W.
    Ozog, David
    Rambhatla, Pranita V.
    DERMATOLOGIC THERAPY, 2021, 34 (02)